Home
>
National Drug Code (NDC)
>
KAZANO
KAZANO - 64764-335-01 - (alogliptin and metformin hydrochloride)
Drug Information of KAZANO
| Product NDC: | 64764-335 |
| Proprietary Name: | KAZANO |
| Non Proprietary Name: | alogliptin and metformin hydrochloride |
| Active Ingredient(s): | 12.5; 500 mg/1; mg/1 & nbsp; alogliptin and metformin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of KAZANO
| Product NDC: | 64764-335 |
| Labeler Name: | Takeda Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203414 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130125 |
Package Information of KAZANO
| Package NDC: | 64764-335-01 |
| Package Description: | 4 CARTON in 1 TRAY (64764-335-01) > 1 BLISTER PACK in 1 CARTON > 14 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of KAZANO
| NDC Code | 64764-335-01 |
| Proprietary Name | KAZANO |
| Package Description | 4 CARTON in 1 TRAY (64764-335-01) > 1 BLISTER PACK in 1 CARTON > 14 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 64764-335 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alogliptin and metformin hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130125 |
| Marketing Category Name | NDA |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
| Strength Number | 12.5; 500 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Biguanide [EPC],Biguanides [Chemical/Ingredient] |
